advertisement
On ZDNet: Saving your data from nuke attack
Find Articles in:
all
Business
Reference
Technology
News
Sports
Health
Autos
Arts
Home & Garden
advertisement

Content provided in partnership with
Thomson / Gale

Nosocomial Burkholderia cepacia infections associated with exposure to sublingual probes—Texas, 2004

Morbidity and Mortality Weekly Report,  Sept 3, 2004  by P. Metcalf,  K. Newman,  J.D. Siegel,  N. Pascoe,  D. Terashita,  L. Mascola,  A. Srinivasan,  M. Arduino,  R. Taylor

On August 27, this notice was posted as ah MMWR Dispatch on the MMWR website (http://www.cdc.gov/mmwr).

Burkholderia cepacia (formerly known as Pseudomonas cepacia, a gram-negative rod [GNR]) is attributed to nosocomial infections among intensive care unit patients and associated with use of contaminated equipment and solutions (1-4). In August 2004, the Texas Department of Health received reports of positive cultures for B. cepacia from respiratory samples of 13 intensive care unit patients receiving mechanical ventilation at a hospital in Texas during April-August 2004. None of the patients had cystic fibrosis, a condition commonly associated with B. cepacia. Initial investigation by the hospital's infection-control team revealed that nearly all of the patients had been exposed to a sublingual probe indicated for use for monitoring tissue carbon dioxide levels. The probe, an SLS-1 Sublingual Sensor, is part of the Nellcor[R] CapnoProbe[TM] Sublingual System (model N-80 monitor), ah FDA-regulated medical device (Nellcor, Pleasanton, California). Each probe is packaged in a metal canister filled with a buffered saline solution and sealed in a foil envelope labeled as nonsterile. Each disposable sensor is used only once.

Most Popular Articles in Health
Fuel your workout: exercisers who eat before they work out have more energy ...
Soothe a dry, itchy scalp: 5 easy expert solutions
Cocktails and calories: Beer, wine and liquor calories can really add up. ...
The sour truth about apple cider vinegar - evaluation of therapeutic use
The, six best supplements you've never heard of: these secret weapons can ...
More »
advertisement

Cultures of the buffered saline solution from at least two lots of unopened probes yielded B. cepacia and other GNRs. B. cepacia isolates from some patients and unopened sensor canisters were indistinguishable by pulsed field gel electrophoresis analysis at the Texas Department of Health laboratory. Investigations into other reports of B. cepacia and other GNRs that might be associated with use of the probes is ongoing at hospitals in Texas and California. The manufacturer has issued a voluntary recall of all SLS-1 Sublingual Sensors.

Clinicians should be aware that patients exposed to these probes might have been exposed to various GNRs, including B. cepacia. Recovery of B. cepacia or GNRs that might be related to use of a sublingual carbon dioxide sensor should be reported to state health departments and CDC's Division of Healthcare Quality and Promotion, telephone 800-893-0485. Health-care facilities are encouraged to report through the voluntary MedWatch reporting program any events not reported under the mandatory process. Additional information is available at http://www.fda.gov/cdrh/mdr/index.html or telephone 800-FDA-1088. Users of this probe should return existing inventory of unused SLS-1 Sublingual Senors by contacting Nellcor's Technical Services department, telephone 800-635-5267, option 3.

References

(1.) CDC. Manufacturer's recall of nasal spray contaminated with Burkholderia cepacia complex. MMWR 2004;53:246.

(2.) Nasser RM, Rahi AC, Haddad MF, Daoud Z, Irani-Hakime N, Almawi WY. Outbreak of Burkholderia cepacia bacteremia traced to contaminated hospital water used for dilution of ah alcohol skin antiseptic. Infect Control Hosp Epidemiol 2004;25:189-91.

(3.) Shehabi AA, Abu-Al-Soud WA, Mahafzah A, et al. Investigation of Burkholderia cepacia nosocomial outbreak with high fatality in patients suffering from diseases other than cystic fibrosis. Scand J Infect Dis 2004;36:174-8.

(4.) LiPuma JJ. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr Opin Pulm Med 1998;4:337-41.

Reported by: P Metcalf, K Newman, JD Siegel, MD, Children's Medical Center, Dallas; N Pascoe, Texas Dept of Health. D Terashita, MD, L Mascola, MD, Los Angeles County Dept of Health Svcs, California. A Srinivasan, MD, M Arduino, PhD, Div of Healthcare Quality Promotion, National Center for Infectious Diseases; R Taylor, PhD, EIS Officer, CDC.

COPYRIGHT 2004 U.S. Government Printing Office
COPYRIGHT 2004 Gale Group